Page last updated: 2024-10-25

cimetidine and Basal Ganglia Diseases

cimetidine has been researched along with Basal Ganglia Diseases in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Handler, CE1
Besse, CP1
Wilson, AO1

Other Studies

1 other study available for cimetidine and Basal Ganglia Diseases

ArticleYear
Extrapyramidal and cerebellar syndrome with encephalopathy associated with cimetidine.
    Postgraduate medical journal, 1982, Volume: 58, Issue:682

    Topics: Aged; Basal Ganglia Diseases; Cerebellar Diseases; Cimetidine; Cognition Disorders; Confusion; Guani

1982